XML 118 R105.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' (DEFICIT) EQUITY - USD ($)
Common Stock
Additional Paid-in Capital
10% Warrants
Additional Paid-in Capital
15% Warrants
Additional Paid-in Capital
Accumulated Deficit
10% Warrants
15% Warrants
Total
Balance at the beginning of the year at Dec. 31, 2018 $ 36,223     $ 56,303,061 $ (51,787,947)     $ 4,551,337
Balance at the beginning of the year (in Shares) at Dec. 31, 2018 36,222,752              
Common stock issued upon exercise of stock options $ 270     188,500       188,770
Common stock issued upon exercise of stock options (in shares) 269,728              
Warrants issued with Notes     $ 158,100       $ 158,100  
Sale of common stock, net of issuance costs $ 3,000     503,614       506,614
Sale of common stock, net of issuance costs (in shares) 3,000,000              
Common stock issued for property and equipment $ 5     7,995       8,000
Common stock issued for property and equipment (in shares) 5,000              
Stock options granted to employees and consultants       3,885,964       3,885,964
Net loss         (15,483,797)     (15,483,797)
Balance at the end of the year at Dec. 31, 2019 $ 39,498     61,468,034 (67,271,744)     (5,764,212)
Balance at the end of the year(in Shares) at Dec. 31, 2019 39,497,480              
Warrants issued with Notes     835,499       835,499  
Common stock issued upon exercise of warrants $ 200     172,041       172,241
Common stock issued upon exercise of warrants (in shares) 200,000              
Common stock issued to employees for services $ 43     99,957       100,000
Common stock issued to employees in services ( in shares) 42,735              
Common stock issued upon conversion of debt $ 541     249,459       250,000
Common stock issued upon conversion of debt (in shares) 541,666              
Expense in relation to beneficial conversion feature       233,500       233,500
Stock options granted to employees and consultants       492,331       492,331
Net loss         (2,014,179)     (2,014,179)
Balance at the end of the year at Mar. 31, 2020 $ 40,282     63,550,821 (69,285,923)     (5,694,820)
Balance at the end of the year(in Shares) at Mar. 31, 2020 40,281,881              
Balance at the beginning of the year at Dec. 31, 2019 $ 39,498     61,468,034 (67,271,744)     (5,764,212)
Balance at the beginning of the year (in Shares) at Dec. 31, 2019 39,497,480              
Warrants issued with Notes   $ 385,400 $ 835,499     $ 385,400 $ 835,499  
Common stock issued upon exercise of warrants $ 200     172,041       172,241
Common stock issued upon exercise of warrants (in shares) 200,000              
Common stock issued to employees for services $ 43     99,957       100,000
Common stock issued to employees in services ( in shares) 42,735              
Common stock issued upon conversion of debt $ 2,215     954,841       957,056
Common stock issued upon conversion of debt (in shares) 2,215,892              
Beneficial conversion feature       233,500       233,500
Cashless exercise of warrants $ 2,466     3,204,763       3,207,229
Cashless exercise of warrants (in shares) 2,466,439              
Sale of common stock, net of issuance costs $ 7,532     2,992,468       3,000,000
Sale of common stock, net of issuance costs (in shares) 7,532,010              
Common stock issued for acquisition of SevenFive Farms $ 8,859     3,800,092       3,808,951
Common stock issued for acquisition of SevenFive Farms (in shares) 8,859,117              
Stock options granted to employees and consultants       1,424,146       1,424,146
Modification of warrants       320,673       320,673
Net loss         (7,679,692)     (7,679,692)
Balance at the end of the year at Dec. 31, 2020 $ 60,813     75,891,414 (74,951,436)     1,000,791
Balance at the end of the year(in Shares) at Dec. 31, 2020 60,813,673              
Common stock issued to a consultant $ 112     99,888       100,000
Common stock issued to a consultant (in Shares) 112,359              
Common stock issued upon exercise of stock options $ 214     134,788       135,002
Common stock issued upon exercise of stock options (in shares) 213,860              
Beneficial conversion feature       417,539       417,539
Cashless exercise of warrants $ 1,005     1,556,073       1,557,078
Cashless exercise of warrants (in shares) 1,006,623              
Stock options granted to employees and consultants       103,932       103,932
Warrants issued with Notes   $ 429,300       $ 429,300    
Net loss         (2,359,068)     (2,359,068)
Balance at the end of the year at Mar. 31, 2021 $ 62,144     $ 78,632,934 $ (77,310,504)     $ 1,384,574
Balance at the end of the year(in Shares) at Mar. 31, 2021 62,146,515